501 related articles for article (PubMed ID: 28410587)
1. Overview of cancer incidence and mortality among people living with HIV/AIDS in British Columbia, Canada: Implications for HAART use and NADM development.
Chiu CG; Smith D; Salters KA; Zhang W; Kanters S; Milan D; Montaner JSG; Coldman A; Hogg RS; Wiseman SM
BMC Cancer; 2017 Apr; 17(1):270. PubMed ID: 28410587
[TBL] [Abstract][Full Text] [Related]
2. Characteristics of non-AIDS-defining malignancies in the HAART era: a clinico-epidemiological study.
Dauby N; De Wit S; Delforge M; Necsoi VC; Clumeck N
J Int AIDS Soc; 2011 Mar; 14():16. PubMed ID: 21443771
[TBL] [Abstract][Full Text] [Related]
3. Ten-year survival among HIV-1-infected subjects with AIDS or non-AIDS-defining malignancies.
Spagnuolo V; Galli L; Salpietro S; Gianotti N; Guffanti M; Cossarini F; Bigoloni A; Cinque P; Bossolasco S; Travi G; Fumagalli L; Lazzarin A; Castagna A
Int J Cancer; 2012 Jun; 130(12):2990-6. PubMed ID: 21796633
[TBL] [Abstract][Full Text] [Related]
4. AIDS incidence and AIDS-related mortality in British Columbia, Canada, between 1981 and 2013: a retrospective study.
Lima VD; Lourenço L; Yip B; Hogg RS; Phillips P; Montaner JS
Lancet HIV; 2015 Mar; 2(3):e92-7. PubMed ID: 25780802
[TBL] [Abstract][Full Text] [Related]
5. Cancer incidence among HIV-positive women in British Columbia, Canada: Heightened risk of virus-related malignancies.
Salters KA; Cescon A; Zhang W; Ogilvie G; Murray MC; Coldman A; Hamm J; Chiu CG; Montaner JS; Wiseman SM; Money D; Pick N; Hogg RS
HIV Med; 2016 Mar; 17(3):188-95. PubMed ID: 26268461
[TBL] [Abstract][Full Text] [Related]
6. Mortality among people living with HIV/AIDS with non-small-cell lung cancer in the modern HAART Era.
Smith DM; Salters KA; Eyawo O; Franco-Villalobos C; Jabbari S; Wiseman SM; Press N; Montaner JSG; Man SFP; Hull M; Hogg RS
AIDS Care; 2018 Jul; 30(7):936-942. PubMed ID: 29411625
[TBL] [Abstract][Full Text] [Related]
7. Cancer incidence in people living with HIV/AIDS in Israel, 1981-2010.
Zohar M; Micha B
AIDS Res Hum Retroviruses; 2015 Sep; 31(9):873-81. PubMed ID: 25941873
[TBL] [Abstract][Full Text] [Related]
8. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.
Clifford GM; Polesel J; Rickenbach M; Dal Maso L; Keiser O; Kofler A; Rapiti E; Levi F; Jundt G; Fisch T; Bordoni A; De Weck D; Franceschi S;
J Natl Cancer Inst; 2005 Mar; 97(6):425-32. PubMed ID: 15770006
[TBL] [Abstract][Full Text] [Related]
9. HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies.
Monforte Ad; Abrams D; Pradier C; Weber R; Reiss P; Bonnet F; Kirk O; Law M; De Wit S; Friis-Møller N; Phillips AN; Sabin CA; Lundgren JD;
AIDS; 2008 Oct; 22(16):2143-53. PubMed ID: 18832878
[TBL] [Abstract][Full Text] [Related]
10. Cause-specific mortality after diagnosis of cancer among HIV-positive patients: A collaborative analysis of cohort studies.
Trickey A; May MT; Gill MJ; Grabar S; Vehreschild J; Wit FWNM; Bonnet F; Cavassini M; Abgrall S; Berenguer J; Wyen C; Reiss P; Grabmeier-Pfistershammer K; Guest JL; Shepherd L; Teira R; d'Arminio Monforte A; Del Amo J; Justice A; Costagliola D; Sterne JAC
Int J Cancer; 2020 Jun; 146(11):3134-3146. PubMed ID: 32003460
[TBL] [Abstract][Full Text] [Related]
11. AIDS malignancies in the era of highly active antiretroviral therapy.
Gates AE; Kaplan LD
Oncology (Williston Park); 2002 May; 16(5):657-65; discussion 665, 668-70. PubMed ID: 12108891
[TBL] [Abstract][Full Text] [Related]
12. Impact of highly active antiretroviral therapy on the morbidity and mortality in Spanish human immunodeficiency virus-infected children.
Sánchez JM; Ramos Amador JT; Fernández de Miguel S; González Tomée MI; Rojo Conejo P; Ferrnado Vivas P; Clemente Vivas J; Ruiz Contreras J; Nogales Espert A
Pediatr Infect Dis J; 2003 Oct; 22(10):863-7. PubMed ID: 14551485
[TBL] [Abstract][Full Text] [Related]
13. Cancer survival in patients with HIV/AIDS in the era of highly active antiretroviral therapy in Taiwan: a population-based cohort study.
Lin CS; Lin C; Weng SF; Lin SW; Lin YS
Cancer Epidemiol; 2013 Oct; 37(5):719-24. PubMed ID: 23770024
[TBL] [Abstract][Full Text] [Related]
14. Long-term cancer risk among people diagnosed with AIDS during childhood.
Simard EP; Shiels MS; Bhatia K; Engels EA
Cancer Epidemiol Biomarkers Prev; 2012 Jan; 21(1):148-54. PubMed ID: 22068287
[TBL] [Abstract][Full Text] [Related]
15. Cohort Profile: HAART Observational Medical Evaluation and Research (HOMER) cohort.
Patterson S; Cescon A; Samji H; Cui Z; Yip B; Lepik KJ; Moore D; Lima VD; Nosyk B; Harrigan PR; Montaner JS; Shannon K; Wood E; Hogg RS
Int J Epidemiol; 2015 Feb; 44(1):58-67. PubMed ID: 24639444
[TBL] [Abstract][Full Text] [Related]
16. Noninfectious pulmonary complications of HIV/AIDS.
Kanmogne GD
Curr Opin Pulm Med; 2005 May; 11(3):208-12. PubMed ID: 15818181
[TBL] [Abstract][Full Text] [Related]
17. Mortality and progression to AIDS after starting highly active antiretroviral therapy.
van Sighem AI; van de Wiel MA; Ghani AC; Jambroes M; Reiss P; Gyssens IC; Brinkman K; Lange JM; de Wolf F;
AIDS; 2003 Oct; 17(15):2227-36. PubMed ID: 14523280
[TBL] [Abstract][Full Text] [Related]
18. Expansion of HAART coverage is associated with sustained decreases in HIV/AIDS morbidity, mortality and HIV transmission: the "HIV Treatment as Prevention" experience in a Canadian setting.
Montaner JS; Lima VD; Harrigan PR; Lourenço L; Yip B; Nosyk B; Wood E; Kerr T; Shannon K; Moore D; Hogg RS; Barrios R; Gilbert M; Krajden M; Gustafson R; Daly P; Kendall P
PLoS One; 2014; 9(2):e87872. PubMed ID: 24533061
[TBL] [Abstract][Full Text] [Related]
19. Highly active antiretroviral therapy and the incidence of non-AIDS-defining cancers in people with HIV infection.
Powles T; Robinson D; Stebbing J; Shamash J; Nelson M; Gazzard B; Mandelia S; Møller H; Bower M
J Clin Oncol; 2009 Feb; 27(6):884-90. PubMed ID: 19114688
[TBL] [Abstract][Full Text] [Related]
20. The impact of highly active antiretroviral therapy on non-AIDS-defining cancers among adults with AIDS.
Hessol NA; Pipkin S; Schwarcz S; Cress RD; Bacchetti P; Scheer S
Am J Epidemiol; 2007 May; 165(10):1143-53. PubMed ID: 17344204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
